META vs MPU

META exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial strength across most key metrics. While the current price of $671.34 trades at a significant premium to the Graham Number ($213.08) and the growth-based Intrinsic Value ($541.67), this is justified by a highly attractive Forward P/E of 18.62 and a PEG ratio of 1.10. The company maintains elite profitability margins (82% Gross, 41.3% Operating) and robust revenue growth of 23.8% YoY. Despite bearish insider sentiment and short-term technical weakness, the underlying operational performance and analyst consensus suggest significant upside toward the $855 target.

MPU exhibits critical financial distress, highlighted by a Piotroski F-Score of 1/9, indicating severe fundamental weakness. The company is suffering from a massive revenue collapse (-49.20% YoY) and extreme operational inefficiency with an operating margin of -376.36%. While the current ratio of 4.06 suggests short-term liquidity, the combination of a 0/100 technical trend and consistent earnings misses points to a failing business model. The stock is in a long-term structural decline, losing over 72% of its value over the last five years.